Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies against NKG2A

Monoclonal antibodies against NKG2A

US Patent 10160810 · Granted Dec 25, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment regimens using anti-NKG2A antibodies2024
Neutralization of inhibitory pathways in lymphocytes2023
Compositions and methods for regulating NK cell activity2022
Treatment of cancers using anti-NKG2A agents2022
Neutralization of inhibitory pathways in lymphocytes2020
Neutralization of inhibitory pathways in lymphocytes2020
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer2020
Enzymatic conjugation of antibodies2020
Treatment regimens using anti-NKG2A antibodies2020
Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma2019
Enzymatic conjugation of polypeptides2019
Treatment of cancers using anti-NKG2A agents2019